Elanco Animal Health (ELAN) Competitors $17.89 +0.40 (+2.30%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$17.85 -0.04 (-0.23%) As of 08/22/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ELAN vs. ONC, BNTX, INSM, TEVA, SMMT, GMAB, VTRS, ASND, RDY, and QGENShould you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include BeOne Medicines (ONC), BioNTech (BNTX), Insmed (INSM), Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Viatris (VTRS), Ascendis Pharma A/S (ASND), Dr. Reddy's Laboratories (RDY), and QIAGEN (QGEN). These companies are all part of the "pharmaceutical products" industry. Elanco Animal Health vs. Its Competitors BeOne Medicines BioNTech Insmed Teva Pharmaceutical Industries Summit Therapeutics Genmab A/S Viatris Ascendis Pharma A/S Dr. Reddy's Laboratories QIAGEN BeOne Medicines (NASDAQ:ONC) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation, dividends and media sentiment. Which has higher earnings & valuation, ONC or ELAN? Elanco Animal Health has higher revenue and earnings than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeOne Medicines$3.81B9.02-$644.79M-$1.73-181.31Elanco Animal Health$4.44B2.00$338M$0.8620.81 Which has more volatility & risk, ONC or ELAN? BeOne Medicines has a beta of 0.27, suggesting that its stock price is 73% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.66, suggesting that its stock price is 66% more volatile than the S&P 500. Do analysts recommend ONC or ELAN? BeOne Medicines presently has a consensus target price of $330.89, suggesting a potential upside of 5.49%. Elanco Animal Health has a consensus target price of $17.33, suggesting a potential downside of 3.13%. Given BeOne Medicines' stronger consensus rating and higher probable upside, equities research analysts clearly believe BeOne Medicines is more favorable than Elanco Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BeOne Medicines 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Elanco Animal Health 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78 Is ONC or ELAN more profitable? Elanco Animal Health has a net margin of 9.68% compared to BeOne Medicines' net margin of -3.89%. Elanco Animal Health's return on equity of 7.04% beat BeOne Medicines' return on equity.Company Net Margins Return on Equity Return on Assets BeOne Medicines-3.89% -1.22% -0.72% Elanco Animal Health 9.68%7.04%3.45% Do insiders & institutionals hold more shares of ONC or ELAN? 48.6% of BeOne Medicines shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 6.6% of BeOne Medicines shares are held by insiders. Comparatively, 0.9% of Elanco Animal Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media prefer ONC or ELAN? In the previous week, Elanco Animal Health had 3 more articles in the media than BeOne Medicines. MarketBeat recorded 11 mentions for Elanco Animal Health and 8 mentions for BeOne Medicines. BeOne Medicines' average media sentiment score of 1.23 beat Elanco Animal Health's score of 1.01 indicating that BeOne Medicines is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeOne Medicines 4 Very Positive mention(s) 4 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elanco Animal Health 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryElanco Animal Health beats BeOne Medicines on 11 of the 17 factors compared between the two stocks. Get Elanco Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAN vs. The Competition Export to ExcelMetricElanco Animal HealthMED IndustryMedical SectorNYSE ExchangeMarket Cap$8.90B$4.12B$5.83B$21.32BDividend YieldN/A1.24%4.40%3.51%P/E Ratio20.8126.9631.3029.14Price / Sales2.00177.04454.6055.18Price / Cash7.9527.2138.0224.09Price / Book1.312.929.535.47Net Income$338M$189.47M$3.26B$992.74M7 Day Performance-0.43%3.00%2.14%2.68%1 Month Performance19.17%14.08%2.81%1.53%1 Year Performance22.89%15.65%30.70%10.77% Elanco Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELANElanco Animal Health3.0898 of 5 stars$17.89+2.3%$17.33-3.1%+22.4%$8.90B$4.44B20.819,000Analyst DowngradeONCBeOne Medicines0.8668 of 5 stars$319.32-0.6%$330.89+3.6%N/A$35.22B$3.81B0.0011,000Positive NewsBNTXBioNTech1.7516 of 5 stars$112.55-0.9%$135.80+20.7%+27.1%$27.29B$2.98B-70.346,772INSMInsmed4.0049 of 5 stars$127.27-0.4%$129.57+1.8%+66.9%$27.01B$363.71M-22.291,271Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionTEVATeva Pharmaceutical Industries3.9425 of 5 stars$18.08+1.2%$24.71+36.7%+0.4%$20.48B$16.54B-113.0036,830Positive NewsSMMTSummit Therapeutics2.3902 of 5 stars$26.29-1.5%$35.00+33.1%+93.8%$19.83B$700K-26.03110Analyst ForecastGMABGenmab A/S3.8466 of 5 stars$23.42+0.5%$37.60+60.5%-8.8%$14.95B$3.12B13.632,682Positive NewsAnalyst DowngradeVTRSViatris1.6145 of 5 stars$10.63+0.2%$10.40-2.2%-9.0%$12.37B$14.74B4.4032,000Analyst UpgradeASNDAscendis Pharma A/S3.4382 of 5 stars$194.08-2.1%$242.93+25.2%+39.4%$12.14B$393.54M-37.611,017News CoveragePositive NewsAnalyst ForecastRDYDr. Reddy's Laboratories3.138 of 5 stars$14.26+0.2%$16.95+18.9%-12.1%$11.87B$3.81B21.6027,811News CoverageQGENQIAGEN3.8228 of 5 stars$48.66-1.4%$49.69+2.1%+9.4%$10.97B$1.98B21.035,765Positive News Related Companies and Tools Related Companies ONC Competitors BNTX Competitors INSM Competitors TEVA Competitors SMMT Competitors GMAB Competitors VTRS Competitors ASND Competitors RDY Competitors QGEN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELAN) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elanco Animal Health Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Elanco Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access